Development of novel peptide-based radiotracers for detecting PD-L1 expression and guiding cancer immunotherapy.
Shiyu ZhuBeibei LiangYuxuan ZhouYinfei ChenJiayu FuLing QiuJianguo LinPublished in: European journal of nuclear medicine and molecular imaging (2023)
F]AlF-NOTA-IMB were developed as promising agents for evaluating the immunotherapy effect by monitoring the changes of PD-L1 expression in real time.
Keyphrases